Archives

Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPARα.
Liang N, Damdimopoulos A, Goñi S, Huang Z, Vedin LL, Jakobsson T, Giudici M, Ahmed O, Pedrelli M, Barilla S, Alzaid F, Mendoza A, Schröder T, Kuiper R, Parini P, Hollenberg A, Lefebvre P, Francque S, Van Gaal L, Staels B, Venteclef N, Treuter E, Fan R. Nat Commun. 2019 Apr 11;10(1):1684. doi: 10.1038/s41467-019-09524-z.

Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease Treatment.
Brial F, Le Lay A, Hedjazi L, Tsang T, Fearnside JF, Otto GW, Alzaid F, Wilder SP, Venteclef N, Cazier JB, Nicholson JK, Day C, Burt AD, Gut IG, Lathrop M, Dumas ME, Gauguier D. Sci Rep. 2019 Mar 6;9(1):3656. doi: 10.1038/s41598-019-40153-0.

Isolation and Analysis of Human Monocytes and Adipose Tissue Macrophages.
Julla JB, Ballaire R, Ejlalmanesh T, Gautier JF, Venteclef N, Alzaid F. Methods Mol Biol. 2019;1951:33-48. doi: 10.1007/978-1-4939-9130-3_3.

Checkpoint inhibitor treatment induces an increase in HbA1c in nondiabetic patients.
Gauci ML, Boudou P, Squara PA, Delyon J, Allayous C, Mourah S, Resche-Rigon M, Lebbé C, Baroudjian B, Gautier JF; PATIO group. Melanoma Res. 2019 Jun;29(3):328-332. doi: 10.1097/CMR.0000000000000585.

Lower limb events in individuals with type 2 diabetes: evidence for an increased risk associated with diuretic use.
Potier L, Roussel R, Velho G, Saulnier PJ, Bumbu A, Matar O, Schneider F, Ragot S, Marre M, Mohammedi K, Hadjadj S. Diabetologia. 2019 Jun;62(6):939-947. doi: 10.1007/s00125-019-4835-z. Epub 2019 Feb 26.

Refractory hypotension with fever revealing checkpoint inhibitor-induced hypophysitis.
Plaçais L, Hau E, Delyon J, Azoulay E, Gautier JF, Lebbé C, Baroudjian B; PATIO Group. Melanoma Res. 2019 Apr;29(2):205-207. doi: 10.1097/CMR.0000000000000517.

Rates of Hypoglycemia Predicted in Patients with Type 2 Diabetes on Insulin Glargine 300 U/ml Versus First- and Second-Generation Basal Insulin Analogs: The Real-World LIGHTNING Study.
Pettus J, Roussel R, Liz Zhou F, Bosnyak Z, Westerbacka J, Berria R, Jimenez J, Eliasson B, Hramiak I, Bailey T, Meneghini L. Diabetes Ther. 2019 Apr;10(2):617-633. doi: 10.1007/s13300-019-0568-8.

Severe Chronic Kidney Disease Is Associated with a Lower Efficiency of Bariatric Surgery.
Hansel B, Arapis K, Kadouch D, Ledoux S, Coupaye M, Msika S, Vrtovsnik F, Marre M, Boutten A, Cherifi B, Cambos S, Beslay M, Courie R, Roussel R. Obes Surg. 2019 May;29(5):1514-1520. doi: 10.1007/s11695-019-03703-z.

Letter by Potier and Roussel Regarding Article, “Are We Ready to Bell the Cat? A Call for Cardiologists to Embrace Glucose-Lowering Therapies Proven to Improve Cardiovascular Outcomes”.
Potier L, Roussel R. Circulation. 2019 Jan 8;139(2):303-304. doi: 10.1161/CIRCULATIONAHA.118.037118.

Head-to-head comparison of the diagnostic performances of Rubidium-PET and SPECT with CZT camera for the detection of myocardial ischemia in a population of women and overweight individuals.
Hyafil F, Chequer R, Sorbets E, Estellat C, Ducrocq G, Rouzet F, Alfaiate T, Regaieg H, Abtan J, Leygnac S, Milliner M, Imbert L, Burg S, Ben Azzouna R, Potier L, Laouénan C, Quintin C, Roussel R, Hartemann A, Montalescot G, Marie PY, Steg G, Le Guludec D. J Nucl Cardiol. 2020 Jun;27(3):755-768. doi: 10.1007/s12350-018-01557-z.

Management of immune-related adverse events resulting from immune checkpoint blockade.
Baroudjian B, Arangalage D, Cuzzubbo S, Hervier B, Lebbé C, Lorillon G, Tazi A, Zalcman G, Bouattour M, Lioté F, Gautier JF, Brosseau S, Lourenco N, Delyon J; PATIO group. Expert Rev Anticancer Ther. 2019 Mar;19(3):209-222. doi: 10.1080/14737140.2019.1562342.

Rab4b Deficiency in T Cells Promotes Adipose Treg/Th17 Imbalance, Adipose Tissue Dysfunction, and Insulin Resistance.
Gilleron J, Bouget G, Ivanov S, Meziat C, Ceppo F, Vergoni B, Djedaini M, Soprani A, Dumas K, Jacquel A, Yvan-Charvet L, Venteclef N, Tanti JF, Cormont M. Cell Rep. 2018 Dec 18;25(12):3329-3341.e5. doi: 10.1016/j.celrep.2018.11.083.

Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies.
Pennells L, Kaptoge S, Wood A, Sweeting M,… Roussel R, … Danesh J, Di Angelantonio E; Emerging Risk Factors Collaboration. Eur Heart J. 2019 Feb 14;40(7):621-631. doi: 10.1093/eurheartj/ehy653.

Double-blind, randomized clinical trial comparing the efficacy and safety of continuing or discontinuing the dipeptidyl peptidase-4 inhibitor sitagliptin when initiating insulin glargine therapy in patients with type 2 diabetes: The CompoSIT-I Study.
Roussel R, Duran-García S, Zhang Y, Shah S, Darmiento C, Shankar RR, Golm GT, Lam RLH, O’Neill EA, Gantz I, Kaufman KD, Engel SS. Diabetes Obes Metab. 2019 Apr;21(4):781-790. doi: 10.1111/dom.13574.

Lower extremity arterial disease in patients with diabetes: a contemporary narrative review.
Nativel M, Potier L, Alexandre L, Baillet-Blanco L, Ducasse E, Velho G, Marre M, Roussel R, Rigalleau V, Mohammedi K. Cardiovasc Diabetol. 2018 Oct 23;17(1):138. doi: 10.1186/s12933-018-0781-1.

Adaptive β-Cell Neogenesis in the Adult Mouse in Response to Glucocorticoid-Induced Insulin Resistance.
Courty E, Besseiche A, Do TTH, Liboz A, Aguid FM, Quilichini E, Buscato M, Gourdy P, Gautier JF, Riveline JP, Haumaitre C, Buyse M, Fève B, Guillemain G, Blondeau B. Diabetes. 2019 Jan;68(1):95-108. doi: 10.2337/db17-1314.

Acute phase ketosis-prone atypical diabetes is associated with a pro-inflammatory profile: a case-control study in a sub-Saharan African population.
Lontchi-Yimagou E, Boudou P, Nguewa JL, Noubiap JJ, Kamwa V, Djahmeni EN, Atogho-Tiedeu B, Azabji-Kenfack M, Etoa M, Lemdjo G, Dehayem MY, Mbanya JC, Gautier JF, Sobngwi E. J Diabetes Metab Disord. 2018 Mar 29;17(1):37-43. doi: 10.1007/s40200-018-0336-8. eCollection 2018 Jun.

Type III open tibia fractures in low-resource setting. Part 2: soft-tissue coverage with simple, reliable and replicable pedicle flaps.
Mathieu L, Potier L, Niang CD, Rongiéras F, Duhamel P, Bey E. Med Sante Trop. 2018 Aug 1;28(3):230-236. doi: 10.1684/mst.2018.0810.

Prognostic value of plasma MR-proADM vs NT-proBNP for heart failure in people with type 2 diabetes: the SURDIAGENE prospective study.
Fraty M, Velho G, Gand E, Fumeron F, Ragot S, Sosner P, Mohammedi K, Gellen B, Saulnier PJ, Halimi JM, Montaigne D, Ducrocq G, Rehman M, Marre M, Roussel R, Hadjadj S; SURDIAGENE Study Group. Diabetologia. 2018 Dec;61(12):2643-2653. doi: 10.1007/s00125-018-4727-7. 

GPS2 Deficiency Triggers Maladaptive White Adipose Tissue Expansion in Obesity via HIF1A Activation.
Drareni K, Ballaire R, Barilla S, Mathew MJ, Toubal A, Fan R, Liang N, Chollet C, Huang Z, Kondili M, Foufelle F, Soprani A, Roussel R, Gautier JF, Alzaid F, Treuter E, Venteclef N. Cell Rep. 2018 Sep 11;24(11):2957-2971.e6. doi: 10.1016/j.celrep.2018.08.032.

Effects of hydroquinone-containing creams on capillary glycemia before and after serial hand washings in Africans.
Choukem SP, Efie DT, Djiogue S, Kaze FF, Mboue-Djieka Y, Boudjeko T, Dongo E, Gautier JF, Kengne AP. PLoS One. 2018 Aug 28;13(8):e0202271. doi: 10.1371/journal.pone.0202271. eCollection 2018.

More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT Trial.
Rosenstock J, Cheng A, Ritzel R, Bosnyak Z, Devisme C, Cali AMG, Sieber J, Stella P, Wang X, Frías JP, Roussel R, Bolli GB. Diabetes Care. 2018 Oct;41(10):2147-2154. doi: 10.2337/dc18-0559. 

Prognostic Values of Inflammatory and Redox Status Biomarkers on the Risk of Major Lower-Extremity Artery Disease in Individuals With Type 2 Diabetes.
Nativel M, Schneider F, Saulnier PJ, Gand E, Ragot S, Meilhac O, Rondeau P, Burillo E, Cournot M, Potier L, Velho G, Marre M, Roussel R, Rigalleau V, Mohammedi K, Hadjadj S. Diabetes Care. 2018 Oct;41(10):2162-2169. doi: 10.2337/dc18-0695.

Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes.
Velho G, Ragot S, El Boustany R, Saulnier PJ, Fraty M, Mohammedi K, Fumeron F, Potier L, Marre M, Hadjadj S, Roussel R. Cardiovasc Diabetol. 2018 Aug 2;17(1):110. doi: 10.1186/s12933-018-0753-5.

Impaired Aryl Hydrocarbon Receptor Ligand Production by the Gut Microbiota Is a Key Factor in Metabolic Syndrome.
Natividad JM, Agus A, Planchais J, Lamas B, Jarry AC, Martin R, Michel ML, Chong-Nguyen C, Roussel R, Straube M, Jegou S, McQuitty C, Le Gall M, da Costa G, Lecornet E, Michaudel C, Modoux M, Glodt J, Bridonneau C, Sovran B, Dupraz L, Bado A, Richard ML, Langella P, Hansel B, Launay JM, Xavier RJ, Duboc H, Sokol H. Cell Metab. 2018 Nov 6;28(5):737-749.e4. doi: 10.1016/j.cmet.2018.07.001.